Details of the Drug | DrugMAP

General Information of Drug (ID: DMH2KSG)

Drug Name

TH-9402

Synonyms

174230-05-8; ATIR

Indication

Disease Entry	ICD 11	Status	REF
Graft-versus-host disease	4B24	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C21H15Br2ClN2O3
Canonical SMILES: COC(=O)C1=CC=CC=C1C2=C3C=CC(=[NH2+])C(=C3OC4=C2C=CC(=C4Br)N)Br.[Cl-]
InChI: 1S/C21H14Br2N2O3.ClH/c1-27-21(26)11-5-3-2-4-10(11)16-12-6-8-14(24)17(22)19(12)28-20-13(16)7-9-15(25)18(20)23;/h2-9,24H,25H2,1H3;1H
InChIKey: MUDCDMMNYVJLEB-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 9958880
TTD ID: D09CIF

References

1	ClinicalTrials.gov (NCT02519816) Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD.